Chee Conley - Net Worth and Insider Trading
Chee Conley Net Worth
The estimated net worth of Chee Conley is at least $313,610 dollars as of 2024-11-05. Chee Conley is the President & CEO of Syros Pharmaceuticals Inc and owns about 122,504 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $313,610. Details can be seen in Chee Conley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chee Conley has not made any transactions after 2024-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chee Conley
Chee Conley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chee Conley owns 1 companies in total, including Syros Pharmaceuticals Inc (SYRS) .
Click here to see the complete history of Chee Conley’s form 4 insider trades.
Insider Ownership Summary of Chee Conley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-09-11 | Chief Commercial Officer |
Chee Conley Latest Holdings Summary
Chee Conley currently owns a total of 1 stock. Chee Conley owns 122,504 shares of Syros Pharmaceuticals Inc (SYRS) as of September 11, 2024, with a value of $313,610.
Latest Holdings of Chee Conley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-09-11 | 122,504 | 2.56 | 313,610 |
Holding Weightings of Chee Conley
Chee Conley Form 4 Trading Tracker
According to the SEC Form 4 filings, Chee Conley has made a total of 1 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Syros Pharmaceuticals Inc is the acquisition of 100,000 shares on September 11, 2024, which cost Chee Conley around $161,000.
Insider Trading History of Chee Conley
- 1
Chee Conley Trading Performance
GuruFocus tracks the stock performance after each of Chee Conley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chee Conley is %. GuruFocus also compares Chee Conley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chee Conley within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chee Conley's insider trading performs compared to the benchmark.
Performance of Chee Conley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.25 |  | | | | |
| Relative Return to S&P 500(%) | 15.55 | | | | | |
Chee Conley Ownership Network
Ownership Network List of Chee Conley
Ownership Network Relation of Chee Conley
Chee Conley Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Chee Conley is the Chief Commercial Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Medical Officer David Roth , and Chief Scientific Officer Eric R Olson .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Chee Conley made 1 insider transaction in Syros Pharmaceuticals Inc (SYRS) with a net purchase of 100,000. Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Jason Haas .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Chee Conley Mailing Address
Above is the net worth, insider trading, and ownership report for Chee Conley. You might contact Chee Conley via mailing address: C/o Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
